期刊
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
卷 49, 期 12, 页码 1021-1036出版社
WILEY
DOI: 10.1002/jlcr.1125
关键词
cannabinoid receptor; carbon-11; positron emission tomography; rimonabant; SR141716
Two novel ligands for cerebral cannabinoid receptor (CBI), 1-(2,4-dichlorophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (JHU75528) and 1-(2-bromophenyl)-4-cyano-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide (JHU75575) have been synthesized. Both JHU75528 and JHU75575 display a combination of higher binding affinity and lower lipophilicity than those of Rimonabant (SR141716), a high affinity CBI selective antagonist, and AM281, the only available ligand for emission tomography imaging of CBI in human subjects. Radiolabeled [C-11]JHU75528 and [C-11]JHU75575 were prepared by reaction of [C-11]methyl iodide with nor-methyl precursors. The average radiochemical yield, specific radioactivity, and radiochemical purity of [C-11]JHU75528 were 16%, 235 GBq/mu mol (6360 mCi/mu mol), and 99%, respectively; those of [C-11]JHU75575 were 8%, 196 GBq/mu mol (5308 mCi/mu mol), and 99%, respectively. Both ligands hold promise as PET radioligands for imaging CBI receptor. (c) Copyright 2006 John Wiley & Sons, Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据